{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-009686","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.076658+00:00","generated_at":"2026-05-25T01:29:04.096597+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Hepion shareholders approve reverse stock split (1:10-1:50) at annual meeting","bullets":["All four director nominees elected (Brancaccio, Block, Lbiati, Purcell) with majority 'For' votes.","Ratification of Grassi & Co. as auditor for FY2024 approved: 2,974,800 For, 603,560 Against.","Advisory say-on-pay approved: 1,419,035 For, 853,863 Against, 244,418 Abstentions.","Issuance of shares upon Series A and B Warrants approved: 1,720,659 For, 793,847 Against.","Reverse stock split amendment approved (2,685,475 For); board to set ratio (1:10-1:50) and timing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-009686","json":"https://secwatch.observer/filing/0001493152-25-009686.json","markdown":"https://secwatch.observer/filing/0001493152-25-009686.md","text":"https://secwatch.observer/filing/0001493152-25-009686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000149315225009686/0001493152-25-009686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000149315225009686/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T01:29:04.096597+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}